MedPath

Non-Crossover Study of the LMA Protector Versus Ambu AuraGain

Not Applicable
Completed
Conditions
Airway Morbidity
Interventions
Procedure: function tests
Device: LMA ProtectorTM
Device: Ambu AuraGainTM
Registration Number
NCT02820792
Lead Sponsor
Schulthess Klinik
Brief Summary

The LMA ProtectorTM is a new extraglottic airway device which brings together features of both the LMA ProSealTM (high seal cuff, gastric access and bite block - to facilitate ventilation, airway protection and airway obstruction, respectively) and the LMA UniqueTM (single use - prevention of disease transmission). In the following randomized study the investigators test the hypothesis that ease of insertion, oropharyngeal leak pressure, fiberoptic position and ease of gastric tube placement differ between the LMA ProtectorTM and the Ambu AuraGainTM in paralyzed, anesthetized patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
96
Inclusion Criteria
  • ASA 1 or 2
  • Age 19-65 yr
  • Written informed consent
Exclusion Criteria
  • Difficult airway
  • Non fasted
  • BMI > 35

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Ambu AuraGainTMfunction testsfunction tests: ease of insertion, oropharyngeal seal pressure, fiberoptic position, ease of ventilation, occult blood, gastric tube insertion
LMA ProtectorTMLMA ProtectorTMfunction tests: ease of insertion, oropharyngeal seal pressure, fiberoptic position, ease of ventilation, occult blood, gastric tube insertion
Ambu AuraGainTMAmbu AuraGainTMfunction tests: ease of insertion, oropharyngeal seal pressure, fiberoptic position, ease of ventilation, occult blood, gastric tube insertion
LMA ProtectorTMfunction testsfunction tests: ease of insertion, oropharyngeal seal pressure, fiberoptic position, ease of ventilation, occult blood, gastric tube insertion
Primary Outcome Measures
NameTimeMethod
oropharyngeal leak pressure5 min

Oropharyngeal leak pressure was determined by closing the expiratory valve of the anesthesia breathing system and a fixed gas flow of 3 l minute-1. The airway pressure at which an equilibrium was reached was noted (maximum allowed 40 cm H2O).

Secondary Outcome Measures
NameTimeMethod
anatomic position5 min

The anatomic position was assessed by passing a fiberoptic scope through the airway tube stopping 0,5 cm prior to the end of the tube. The airway tube view was scored using an established scoring system.

Trial Locations

Locations (2)

Christian Keller MD, M.Sc.

🇨🇭

Zürich, Switzerland

Schulthess Klinik

🇨🇭

Zürich, Switzerland

© Copyright 2025. All Rights Reserved by MedPath